Skip to content
healthcare.dev
Get a free key

Trijardy XR

NDC 0597-0385, empagliflozin, linagliptin, metformin hydrochloride, tablet, extended release, from Boehringer Ingelheim Pharmaceuticals, Inc..

Product NDC
0597-0385
Status
Listed
Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212614
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0385 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EMPAGLIFLOZIN12.5 mg/1
  • LINAGLIPTIN2.5 mg/1
  • METFORMIN HYDROCHLORIDE1000 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
0597-0385-770059703857760 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-77)
0597-0385-8600597038586180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/71873567-9594-452a-bb92-34a129adecac

  • NADAC price for package 00597038577

    GET /v1/drugs/nadac/00597038577

  • NADAC price for package 00597038586

    GET /v1/drugs/nadac/00597038586

Use it

Look up 0597-0385 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0385 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0597-0385. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.